Ergoteles LLC Voyager Therapeutics, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.94 - $6.61 $120,432 - $161,145	24,379 New	24,379 $148,000
Q2 2022 Aug 12, 2022	BUY	$4.82 - $10.09 $280,292 - $586,753	58,152 New	58,152 $344,000
Q4 2021 Feb 14, 2022	SELL	$2.47 - $5.55 $269,751 - $606,121	-109,211 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $23,641 - $37,034	-8,989 Reduced 7.6%	109,211 $287,000
Q2 2021 Aug 12, 2021	BUY	$3.94 - $5.44 $465,708 - $643,008	118,200 New	118,200 $488,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.